V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330008410 | 330008837 | 1.65 | 64.75 | Palliative (P) | 2016-10-02 | 2016-10-02 | EURO-EWING | N | N | 330017807 | EURO-EWING |
| 330008411 | 330008839 | 1.73 | 13.4 | Palliative (P) | 2017-03-13 | 2017-03-13 | Methotrexate intrathecal | 02 | N | 330017809 | METHOTREXATE INTRATHECAL |
| 330008412 | 330005207 | 1.67 | 40.3 | Curative (C) | 2014-04-16 | 2014-04-17 | TEMOZOLOMIDE | 02 | N | 330017833 | CISPLATIN + ETOPOSIDE |
| 330008417 | 330005216 | 1.78 | 74.25 | Curative (C) | 2015-04-02 | 2015-04-03 | Cyclophosphamide + Topotecan | N | N | 330017922 | CAV |
| 330008418 | 330005219 | 1.8 | 117 | Palliative (P) | 2016-02-09 | 2016-02-11 | Trabectedin | 1 | N | 330017922 | TRABECTEDIN |
| 330008419 | 330005220 | 1.74 | 114.6 | Palliative (P) | 2017-05-15 | 2017-07-30 | GemCarbo Days 1+8 | 02 | N | 330017933 | GEMCARBO |
| 330008420 | 330005220 | 0 | 86.9 | Palliative (P) | null | 2017-08-30 | Liposomal Doxorubicin (Caelyx) | null | null | 330017933 | LIPOSOMAL DOXORUBICIN |
| 330008421 | 330005220 | 1.67 | 82.7 | Palliative (P) | 2014-12-30 | 2015-02-14 | Docetaxel 75mg/m2 (21 day) | N | N | 330017933 | DOCETAXEL |
| 330008423 | 330005222 | 1.77 | 117 | Curative (C) | 2017-07-09 | 2017-07-09 | DA 3+8 | N | N | 330017957 | DA |
| 330008424 | 330008847 | 1.55 | 71.6 | Curative (C) | 2018-03-30 | 2018-04-07 | FLAG + Idarubicin | N | N | 330017957 | FLAG + IDARUBICIN |
| 330008425 | 330011879 | 0 | 7.7 | Palliative (P) | 2016-09-04 | 2016-09-04 | Etoposide oral | N | N | 330018009 | ETOPOSIDE |
| 330008426 | 330008848 | 1.7 | 87.4 | Disease modification (D) | null | 2016-04-26 | Methotrexate intrathecal | N | N | 330018009 | METHOTREXATE INTRATHECAL |
| 330008427 | 330005227 | null | null | Palliative (P) | 2014-07-14 | 2014-07-14 | EURO-EWING | null | N | 330018024 | EURO-EWING |
| 330008428 | 330010797 | 1.74 | 62.3 | Curative (C) | 2017-12-05 | 2017-12-06 | Cisplatin + Doxorubicin | N | N | 330018044 | CISPLATIN + ETOPOSIDE |
| 330008429 | 330005228 | 1.75 | 49.2 | Palliative (P) | 2015-09-22 | 2015-12-19 | Docetaxel 75mg/m2 (21 day) | N | N | 330018048 | DOCETAXEL |
| 330008430 | 330005229 | 0.74 | 84 | Curative (C) | 2014-12-06 | 2014-12-16 | Liposomal Doxorubicin (Caelyx) | N | N | 330018058 | LIPOSOMAL DOXORUBICIN |
| 330008431 | 330005229 | 1.8 | 51.2 | Palliative (P) | 2018-02-10 | 2018-02-16 | CNS Low Grade Glioma Vinblastine | N | N | 330018058 | CYCLOPHOSPHAMIDE + TOPOTECAN |
| 330008432 | 330005229 | null | 68.2 | null | 2015-03-13 | 2015-03-13 | Cyclophosphamide + Topotecan | null | null | 330018058 | CAV |
| 330008433 | 330005229 | 1.61 | 65 | Adjuvant (A) | 2013-07-03 | 2013-07-03 | Trabectedin | N | N | 330018058 | TRABECTEDIN |
| 330008434 | 330005231 | 1.86 | 69.9 | Disease modification (D) | 2016-04-02 | 2017-01-29 | ETOPOSIDE | N | N | 330018079 | ETOPOSIDE |
| 330008435 | 330008852 | 1.77 | null | null | 2015-11-13 | 2015-11-13 | Cyclophosphamide + Topotecan | 02 | N | 330018083 | CISPLATIN + DOXORUBICIN |
| 330008436 | 330008852 | 0 | 69.6 | Palliative (P) | 2013-06-02 | 2013-06-05 | Cisplatin + Doxorubicin | 2 | N | 330018083 | DA |
| 330008437 | 330005232 | 1.62 | 62.2 | null | 2016-03-23 | 2016-08-25 | CYCLOPHOSPHAMIDE + RITUXIMAB | N | N | 330018101 | CISPLATIN + ETOPOSIDE |
| 330008438 | 330008853 | 1.58 | 65.8 | Palliative (P) | 2015-05-04 | 2015-05-08 | Liposomal Doxorubicin (Caelyx) | 02 | N | 330018108 | LIPOSOMAL DOXORUBICIN |
| 330008439 | 330011882 | null | 51.4 | Palliative (P) | 2017-01-03 | 2017-01-30 | Etoposide oral | N | N | 330018141 | ETOPOSIDE |
| 330008440 | 330011882 | 1.7 | 75 | Disease modification (D) | 2014-03-15 | 2014-04-03 | Methotrexate intrathecal | 02 | N | 330018141 | METHOTREXATE INTRATHECAL |
| 330008441 | 330008854 | 1.81 | 49.9 | Palliative (P) | 2015-02-04 | 2015-02-15 | Trabectedin | N | N | 330018155 | TRABECTEDIN |
| 330008442 | 330005235 | 0 | 84.2 | Curative (C) | 2015-04-29 | 2015-04-29 | EURO-EWING | null | null | 330018158 | EURO-EWING |
| 330008443 | 330005236 | 1.74 | 69 | Curative (C) | 2018-04-28 | 2018-05-23 | EW EuroEwing 99 : VIDE | N | N | 330018158 | EURO-EWING |
| 330008444 | 330005236 | 1.5 | 54.5 | Disease modification (D) | 2016-06-19 | 2016-06-19 | Cytarabine High Dose | N | N | 330018158 | CYTARABINE HIGH DOSE |
| 330008445 | 330005237 | 0 | 88 | Palliative (P) | 2017-07-18 | 2017-08-17 | CARBOPLATIN + GEMCITABINE | N | null | 330018245 | GEMCARBO |
| 330008446 | 330005238 | 1.62 | 0 | Disease modification (D) | null | 2015-04-03 | Etoposide oral | null | null | 330018266 | ETOPOSIDE |
| 330008448 | 330005239 | null | 73 | Palliative (P) | 2017-09-09 | 2017-09-09 | Cisplatin + Doxorubicin | N | N | 330018276 | CAV |
| 330008449 | 330005240 | 1.79 | 65.7 | Disease modification (D) | 2013-11-21 | 2013-11-21 | DA 3+8 | 2 | N | 330018316 | NIVOLUMAB |
| 330008450 | 330005241 | 1.85 | 14.5 | Palliative (P) | 2013-12-28 | 2013-12-28 | EW Rel rEECur Irinotecan/Temozolomide | Y | N | 330018316 | IRINOTECAN + TEMOZOLOMIDE |
| 330008451 | 330005242 | 1.55 | 76 | Palliative (P) | 2017-09-28 | 2017-09-28 | Docetaxel 75mg/m2 (21 day) | 2 | N | 330018368 | DOCETAXEL |
| 330008452 | 330005243 | 1.6 | 63.7 | Curative (C) | 2017-06-11 | 2017-06-11 | FLAG + Idarubicin | N | N | 330018380 | FLAG + IDARUBICIN |
| 330008453 | 330005244 | 1.82 | 48.6 | Palliative (P) | null | 2017-06-21 | Cisplatin + Doxorubicin | 02 | N | 330018393 | TEMOZOLOMIDE |
| 330008454 | 330008859 | 1.68 | null | Palliative (P) | 2016-03-05 | 2016-03-11 | Azacitidine | N | N | 330018401 | AZACITIDINE |
| 330008455 | 330005247 | 1.74 | 82 | Curative (C) | 2014-05-12 | 2014-05-13 | ETOPOSIDE | N | N | 330018404 | ETOPOSIDE |
| 330008456 | 330005247 | 1.69 | null | Curative (C) | 2017-06-27 | 2017-08-21 | AML Int Guide HD Cytarabine (3 + 4) | 2 | N | 330018404 | CYTARABINE HIGH DOSE |
| 330008457 | 330005249 | 0 | 73 | Curative (C) | 2017-03-05 | 2017-03-11 | CNS HGG Temozolomide maintenance | 2 | N | 330018444 | CISPLATIN + ETOPOSIDE |
| 330008458 | 330005250 | 1.62 | 59.4 | Radical (R) | 2015-12-07 | 2015-12-13 | FLAG + Idarubicin | N | N | 330018504 | FLAG + IDARUBICIN |
| 330008459 | 330005250 | 1.62 | 88.3 | Disease modification (D) | 2015-09-25 | 2015-09-25 | Cisplatin + Doxorubicin | 02 | N | 330018504 | AZACITIDINE |
| 330008460 | 330005250 | 0 | 79.3 | Not known (9) | 2013-10-16 | 2013-10-17 | FLAG + Idarubicin | N | N | 330018504 | FLAG + IDARUBICIN |
| 330008461 | 330005250 | 1.68 | null | Disease modification (D) | 2016-05-20 | 2016-06-17 | Liposomal Doxorubicin (Caelyx) | N | N | 330018504 | LIPOSOMAL DOXORUBICIN |
| 330008462 | 330005251 | 1.55 | 71.6 | null | 2013-11-26 | 2013-12-24 | NIVOLUMAB | N | N | 330018542 | CYCLOPHOSPHAMIDE + TOPOTECAN |
| 330008465 | 330005253 | 1.63 | 78.7 | Curative (C) | 2017-12-07 | 2018-04-22 | Trabectedin | 2 | N | 330018575 | TRABECTEDIN |
| 330008466 | 330005253 | 1.63 | 63.5 | Curative (C) | 2016-03-31 | 2016-04-21 | EW EuroEwing 99 : VIDE | N | N | 330018575 | EURO-EWING |
| 330008467 | 330005254 | 0 | 42 | Curative (C) | 2018-02-12 | 2018-02-18 | Methotrexate intrathecal | Y | null | 330018640 | METHOTREXATE INTRATHECAL |